Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Acta odontol. latinoam ; 23(3): 240-243, Dec. 2010. tab
Artigo em Inglês | LILACS | ID: biblio-949668

RESUMO

Gingival overgrowth is an adverse side effect of cyclosporine A (CsA) in the treatment of transplanted patients. The purpose of this study was to evaluate the effects of CsA on new-onset diabetes mellitus and gingival overgrowth in rats, by measuring collagen, nitric oxide and microvascular permeability. Blood glucose level, collagen, nitric oxide level and vascular permeability were determined. Blood glucose level increased significantly from 6.5 +/- 0.9 for the control group to 15+/- 1.2, 17 +/- 1.2 and 21.6+/- 1.6 mM/L at 1, 4 or 8 weeks of CsA treatment, respectively. Collagen (ug HO Proline/mg p) increased significantly from 2.5+/- 0.5 for the control group to 4.2+/- 0.8, 5.9+/- 0.6 and 7.3 +/- 0.8 at 1, 4 or 8 weeks of CsA treatment, respectively. Vascular permeability was 10.3+/- 1.2 for the control group and 15+/-1; 17.2 +/- 1.3, and 22.1+/- 2.1 ug EB/g T; at 1, 4 or 8 weeks of CsA treatment, respectively. Nitric oxide level was 3.5 +/- .9 umol/mg P for the control group and 4+/- 0.2, 8.2+/- 0.9 and 11+/-1 for 1, 2 or 8 weeks of CsA treatment, respectively. These findings appear to indicate that the development of significant gingival changes induced by CsA is related to new-onset of diabetes mellitus during the immunosuppressive treatment.


La hiperplasia gingival es un efecto colateral adverso del tratamiento con ciclosporina A (CsA) en pacientes transplantados. El proposito de este estudio fue evaluar el efecto de CsA en el inicio de diabetes mellitus, la concentracion de colageno, y de oxido nitrico y la permeabilidad capilar gingival. El nivel de glucosa en sangre de los animales controles fue: 6.5+/- 0.9, en tanto que los tratados con CsA fue: 15+/-1.2; 17+/- 1.1 y 21.6+/- 1.6 mM/L a las 1, 4 y 8 semanas respectivamente. El colageno (ug OH prolina/mg p) mostro un aumento significativo en los animales tratados con CsA respecto de los controles: 2.5+/- 0.5; 4.2+/- 0.8; 5.9+/- 0.6; 7.3+/- 0.8 respectivamente a las 1,4 y 8 semanas de tratamiento. Los valores de permeabilidad capilar (ug AE/ g T) fueron: en los animales control 10.3+./- 1.2; en los animales tratados con CsA, a las 1, 4 y 8 semanas 15+/- 1.0; 17.2 +/- 1.3 y 22.1+/- 2.1 respectivamente. Los valores de oxido nitrico (umol/mg p) en los animales control: 3.5+/-0.9; y en los animales tratados con CsA 4+/- 0.2; 8.2+/- 0.9 y 11.2 +/- 1.0 respectivamente. Estos resultados parecen indicar que el desarrollo de los significativos cambios gingivales inducidos por la administracion de CsA esta relacionado con la hiperglucemia temprana que se asocia al tratamiento con inmunosupresores.


Assuntos
Animais , Masculino , Ratos , Ciclosporina/efeitos adversos , Crescimento Excessivo da Gengiva/induzido quimicamente , Hiperglicemia/induzido quimicamente , Imunossupressores/efeitos adversos , Fatores de Tempo , Glicemia/análise , Glicemia/efeitos dos fármacos , Permeabilidade Capilar/efeitos dos fármacos , Distribuição Aleatória , Colágeno/análise , Colágeno/efeitos dos fármacos , Ratos Wistar , Diabetes Mellitus/induzido quimicamente , Corantes , Azul Evans , Gengiva/efeitos dos fármacos , Gengiva/patologia , Óxido Nítrico/análise
2.
Neuropeptides ; 44(2): 187-9, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20092893

RESUMO

Insulin-dependent diabetes mellitus (type 1 diabetes) is an inflammatory autoimmune disease associated with many complications including nephropathy, retinopathy, neuropathy and hyperalgesia. Experimental evidence has shown that the bradykinin B1 receptor (BKB1-R) is involved in the development of type 1 diabetes and found to be upregulated alongside the disease. In the present study the effects of the selective BKB1-R antagonist the R-954 (Ac-Orn-[Oic(2), alpha-MePhe(5), D-beta Nal(7), Ile(8) ]des-Arg(9)-BK and the BKB1-R agonist des Arg(9)-BK (DBK) were studied on diabetic hyperglycemia. Diabetic type 1 was induced in C57 BL/KsJ mdb male mice by five consecutives doses of STZ (45mg/kg i.p.). A glucose tolerance test (GTT) was performed by an intraperitoneal administration of glucose, 8, 12 and 18days after the diabetes induction. The induction of type 1 diabetes provoked a significant hyperglycemia levels in diabetic mice at 12 and 18days after STZ. The administration of R-954 (400microg/kg i.p.) at 12 and 18days after STZ returned the glycemia levels of this animals to normal values. In addition the administration of DKB (300microg/kg i.p.) significantly potentiated the diabetes-induced hyperglycemia; this effect that was totally reversed by R-954. These results provide further evidence for the implication of BKB1-R in the type 1 diabetes mellitus (insulitis).


Assuntos
Glicemia/efeitos dos fármacos , Antagonistas de Receptor B1 da Bradicinina , Bradicinina/análogos & derivados , Diabetes Mellitus Experimental/tratamento farmacológico , Teste de Tolerância a Glucose , Análise de Variância , Animais , Bradicinina/farmacologia , Masculino , Camundongos
3.
Acta Odontol Latinoam ; 23(3): 240-3, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21638966

RESUMO

Gingival overgrowth is an adverse side effect of cyclosporine A (CsA) in the treatment of transplanted patients. The purpose of this study was to evaluate the effects of CsA on new-onset diabetes mellitus and gingival overgrowth in rats, by measuring collagen, nitric oxide and microvascular permeability. Blood glucose level, collagen, nitric oxide level and vascular permeability were determined. Blood glucose level increased significantly from 6.5 +/- 0.9 for the control group to 15 +/- 1.2, 17 +/- 1.2 and 21.6 +/- 1.6 mM/L at 1, 4 or 8 weeks of CsA treatment, respectively. Collagen (ug HO Proline/mg p) increased significantly from 2.5 +/- 0.5 for the control group to 4.2 +/- 0.8, 5.9 +/- 0.6 and 7.3 +/- 0.8 at 1, 4 or 8 weeks of CsA treatment, respectively. Vascular permeability was 10.3 +/- 1.2 for the control group and 15 +/- 1; 17.2 +/- 1.3, and 22.1 +/- 2.1 ug EB/g T; at 1, 4 or 8 weeks of CsA treatment, respectively Nitric oxide level was 3.5 +/- .9 umol/mg P for the control group and 4 +/- 0.2, 8.2 +/- 0.9 and 11 +/- 1 for 1, 2 or 8 weeks of CsA treatment, respectively. These findings appear to indicate that the development of significant gingival changes induced by CsA is related to new-onset of diabetes mellitus during the immunosuppressive treatment.


Assuntos
Ciclosporina/efeitos adversos , Crescimento Excessivo da Gengiva/induzido quimicamente , Hiperglicemia/induzido quimicamente , Imunossupressores/efeitos adversos , Animais , Glicemia/análise , Glicemia/efeitos dos fármacos , Permeabilidade Capilar/efeitos dos fármacos , Colágeno/análise , Colágeno/efeitos dos fármacos , Corantes , Diabetes Mellitus/induzido quimicamente , Azul Evans , Gengiva/efeitos dos fármacos , Gengiva/patologia , Masculino , Óxido Nítrico/análise , Distribuição Aleatória , Ratos , Ratos Wistar , Fatores de Tempo
5.
Prensa méd. argent ; 95(3): 156-161, mayo 2008. ilus
Artigo em Espanhol | LILACS | ID: lil-497670

RESUMO

La ocurrencia de osteoporosis está documentada en diabetes tipo I. el objetivo de este trabajo fue evaluar el efecto del plasma rico en plaquetas (PRP) sobre la cicatrización ósea en ratas diabéticas... Como resultado el grupo control mostró ± 7,76 por ciento vs. 63,12 ± 15,34 porciento del grupo experimental de hueso neoformado (p= 0,0317). Como conclusión estos resultados sugieren un efecto favorecedor del PRP en la cicatrización ósea diabética, y potencialmente en otras fracturas de alto riesgo.


Assuntos
Ratos , Grupos Controle , Diabetes Mellitus/patologia , Osteoporose/patologia , Plasma Rico em Plaquetas , Ratos Wistar/cirurgia
6.
J Oral Sci ; 48(4): 195-9, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17220616

RESUMO

Uncontrolled or poorly controlled diabetes mellitus may be a risk factor for the development of oral complications. The objective of this investigation was to determine the effect of diabetes mellitus progression on inflammatory and structural components of dental pulp. Male Wistar rats were given a single injection of Streptozotocin (STZ), and induction of diabetes was confirmed 24 h later. Dental pulp tissue samples were taken from central incisors and molars of diabetic rats 30 and 90 days after the STZ treatment. Plasma glucose levels in diabetic rats 30 and 90 days after STZ treatment were significantly increased when compared to control rats (P < 0.001). Nitrite and kallikrein levels in dental pulp tissue were higher in diabetic rats 30 days after STZ treatment than in controls, while only nitrite were decreased 90 after of STZ treatment. Myeloperoxidase activity showed changes 30 and 90 days after STZ injection when compared to controls. The activity of alkaline phosphatase showed significant changes 30 and 90 days after STZ treatment. On the other hand the concentration of collagen was decreased in diabetic rats 30 and 90 days after STZ injection. These results suggest that diabetes is a critical factor that has profound effects upon oral tissues, resulting in expression of inflammatory mediators and modifications of structural components of dental pulp.


Assuntos
Polpa Dentária/metabolismo , Diabetes Mellitus Experimental/complicações , Pulpite/etiologia , Fosfatase Alcalina/metabolismo , Animais , Colágeno/metabolismo , Diabetes Mellitus Experimental/induzido quimicamente , Matriz Extracelular/patologia , Calicreínas/biossíntese , Masculino , Óxido Nítrico/metabolismo , Nitritos/metabolismo , Peroxidase/metabolismo , Ratos , Ratos Wistar , Estreptozocina
7.
Prensa méd. argent ; 93(1): 38-43, 2006. ilus
Artigo em Espanhol | BINACIS | ID: bin-122188

RESUMO

Si bien la ocurrencia de osteoporosis está documentada en diabetes tipo 1, el objetivo de este trabajo es caracterizar ciertos cambios morfológicos, morfométricos y biomecánicos en huesos largos de un modelo de esta patología(AU)


Assuntos
Ratos , Diabetes Mellitus Experimental/fisiopatologia , Ratos Wistar/anatomia & histologia , Ratos Wistar/fisiologia , Tíbia/efeitos dos fármacos , Osteoporose/patologia
8.
Prensa méd. argent ; 93(1): 38-43, 2006. ilus
Artigo em Espanhol | LILACS | ID: lil-482612

RESUMO

Si bien la ocurrencia de osteoporosis está documentada en diabetes tipo 1, el objetivo de este trabajo es caracterizar ciertos cambios morfológicos, morfométricos y biomecánicos en huesos largos de un modelo de esta patología


Assuntos
Ratos , Diabetes Mellitus Experimental , Osteoporose , Ratos Wistar , Tíbia
9.
J Pineal Res ; 39(4): 386-91, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16207294

RESUMO

In rats turned hyperglycemic by a subtotal pancreatectomy, a decreased relaxation response of aortic rings to acetylcholine (ACh) was found; this effect was amplified by preincubation in a high glucose medium (44 mmol/L). The relaxation response to ACh did not occur in endothelium-denuded rings or after the aortic rings were exposed to l-nitro-arginine methyl ester [L-NAME, a nitric oxide (NO) synthase inhibitor]. Incubation with the NO donor sodium nitroprusside (SNP) restored the impaired relaxation response seen in endothelium-denuded or L-NAME-treated aortic rings. Pancreatectomy decreased the vasorelaxation of aortic rings caused by SNP. Only in pancreatectomized rats, incubation in a high glucose medium impaired the relaxation effect of SNP. To assess whether melatonin preincubation reversed the impaired relaxation response to ACh (intact endothelium aortic rings) or to SNP (endothelium-denuded or L-NAME-treated rings) in hyperglycemic rats, cumulative dose-response curves were performed in the presence of 10(-5) mol/L melatonin. Melatonin preincubation did not modify ACh-induced relaxation of aortic rings in a normal glucose concentration but was highly effective in preventing the impairment of relaxation caused by a high glucose solution. Melatonin was also effective in restoring the impaired SNP-induced vasorelaxation seen in endothelium-denuded or L-NAME-treated aortic rings from hyperglycemic rats. The results further support the improvement by melatonin of the endothelial-mediated relaxation in blood vessels of diabetic rats.


Assuntos
Aorta/efeitos dos fármacos , Diabetes Mellitus Experimental/fisiopatologia , Diabetes Mellitus Tipo 1/fisiopatologia , Melatonina/farmacologia , Pancreatectomia , Acetilcolina/farmacologia , Animais , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/fisiologia , Glucose/administração & dosagem , Glucose/farmacologia , Masculino , Relaxamento Muscular/efeitos dos fármacos , NG-Nitroarginina Metil Éster/farmacologia , Nitroprussiato/farmacologia , Ratos , Ratos Wistar
10.
Life Sci ; 74(25): 3085-92, 2004 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-15081574

RESUMO

The present study was undertaken to assess whether the improvement of contractile performance of aortic rings by melatonin described in streptozotocin diabetic rats also occurs in another model of type I diabetes, the pancreatectomized rats. Adult male Wistar rats submitted to a subtotal pancreatectomy and exhibiting altered levels of fasting glucose and an abnormal tolerance glucose test, were used. Sham-operated laparotomized rats were employed as controls. Dose-response curves for acetylcholine-induced, endothelium-related relaxation of aortic rings (after previous exposure to phenylephrine) and for phenylephrine-induced vasoconstriction were conducted. This protocol was repeated with rings pre-incubated in a high glucose solution (44 mmol/l). Pancreatectomy decreased significantly acetylcholine-induced relaxation of aortic rings, but not phenylephrine-induced vasoconstriction, the effect being amplified by preincubation in high glucose solution. The deleterious effect of a high glucose medium was more pronounced in pancreatectomized rats. Melatonin (10(-5) M) did not modify acetylcholine-induced relaxation in normal glucose concentration but was effective to prevent the impairment of relaxation brought about by exposure to high glucose solution. The contractile response to phenylephrine of aortic rings obtained from pancreatectomized rats was not affected by melatonin. The results further support the improvement by melatonin of endothelial-mediated relaxation in blood vessels of diabetic rats.


Assuntos
Diabetes Mellitus Experimental/fisiopatologia , Endotélio Vascular/efeitos dos fármacos , Melatonina/farmacologia , Relaxamento Muscular/efeitos dos fármacos , Pancreatectomia , Vasoconstrição/efeitos dos fármacos , Acetilcolina/farmacologia , Agonistas alfa-Adrenérgicos/farmacologia , Animais , Aorta/efeitos dos fármacos , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 1/tratamento farmacológico , Diabetes Mellitus Tipo 1/fisiopatologia , Endotélio Vascular/fisiologia , Glucose/metabolismo , Teste de Tolerância a Glucose , Laparotomia , Masculino , Fenilefrina/farmacologia , Ratos , Ratos Wistar , Vasodilatadores/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA